The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Annual report to the nation on the status of cancer, part I: National cancer statistics
Open accessAbstract
Background: The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States. Methods: Data on new cancer diagnoses during 2001 through 2016 were obtained from the Centers for Disease Control and Prevention‐funded and National Cancer Institute‐funded population‐based cancer registry programs and compiled by the North American Association of Central Cancer Registries. Data on cancer deaths during 2001 through 2017 were obtained from the National Center for Health Statistics' National Vital Statistics System. Trends in incidence and death rates for all cancers combined and for the leading cancer types by sex, racial/ethnic group, and age were estimated by joinpoint analysis and characterized by the average annual percent change during the most recent 5 years (2012‐2016 for incidence and 2013‐2017 for mortality). Results: Overall, cancer incidence rates decreased 0.6% on average per year during 2012 through 2016, but trends differed by sex, racial/ethnic group, and cancer type. Among males, cancer incidence rates were stable overall and among non‐Hispanic white males but decreased in other racial/ethnic groups; rates increased for 5 of the 17 most common cancers, were stable for 7 cancers (including prostate), and decreased for 5 cancers (including lung and bronchus [lung] and colorectal). Among females, cancer incidence rates increased during 2012 to 2016 in all racial/ethnic groups, increasing on average 0.2% per year; rates increased for 8 of the 18 most common cancers (including breast), were stable for 6 cancers (including colorectal), and decreased for 4 cancers (including lung). Overall, cancer death rates decreased 1.5% on average per year during 2013 to 2017, decreasing 1.8% per year among males and 1.4% per year among females. During 2013 to 2017, cancer death rates decreased for all cancers combined among both males and females in each racial/ethnic group, for 11 of the 19 most common cancers among males (including lung and colorectal), and for 14 of the 20 most common cancers among females (including lung, colorectal, and breast). The largest declines in death rates were observed for melanoma of the skin (decreasing 6.1% per year among males and 6.3% among females) and lung (decreasing 4.8% per year among males and 3.7% among females). Among children younger than 15 years, cancer incidence rates increased an average of 0.8% per year during 2012 to 2016, and cancer death rates decreased an average of 1.4% per year during 2013 to 2017. Among adolescents and young adults aged 15 to 39 years, cancer incidence rates increased an average of 0.9% per year during 2012 to 2016, and cancer death rates decreased an average of 1.0% per year during 2013 to 2017. Conclusions: Although overall cancer death rates continue to decline, incidence rates are leveling off among males and are increasing slightly among females. These trends reflect population changes in cancer risk factors, screening test use, diagnostic practices, and treatment advances. Many cancers can be prevented or treated effectively if they are found early. Population‐based cancer incidence and mortality data can be used to inform efforts to decrease the cancer burden in the United States and regularly monitor progress toward goals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Self-citationWolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21457 · Cited by 1,944
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., Sherman, R. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx030 · Cited by 1,556
Self-citationAnnual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A., Howlader, N., Henley, S. J., Anderson, R. N., Firth, A. U., Ma, J., et al. (2018) · Cancer · doi:10.1002/cncr.31551 · Cited by 1,485
Self-citationScreening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10897 · Cited by 1,409
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Luke, J. J., Flaherty, K. T., Ribas, A., & Long, G. V. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.43 · Cited by 1,254
Cancer Progress and Priorities: Lung Cancer
Schabath, M. B., & Cote, M. L. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0221 · Cited by 1,160
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Center, M. M., Ward, E., Wu, X.-C., Eheman, C., Anderson, R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 957
Self-citationRyerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Self-citationSturgis, E. M., & Cinciripini, P. M. (2007) · Cancer · doi:10.1002/cncr.22963 · Cited by 756
Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer
Reck, M., & Rabe, K. F. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1703413 · Cited by 725
Kohler, B. A., Ward, E., McCarthy, B. J., Schymura, M. J., Ries, L. A. G., Eheman, C., Jemal, A., Anderson, R. N., Ajani, U. A., & Edwards, B. K. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr077 · Cited by 713
Self-citationSmith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21446 · Cited by 571
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
Jemal, A., Fedewa, S. A., Ma, J., Siegel, R., Lin, C. C., Brawley, O., & Ward, E. M. (2015) · JAMA · doi:10.1001/jama.2015.14905 · Cited by 469
Self-citationEheman, C., Henley, S. J., Ballard‐Barbash, R., Jacobs, E. J., Schymura, M. J., Noone, A., Pan, L., Anderson, R. N., Fulton, J. E., Kohler, B. A., et al. (2012) · Cancer · doi:10.1002/cncr.27514 · Cited by 457
Self-citationTesticular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Gilligan, T., Lin, D. W., Aggarwal, R., Chism, D., Cost, N., Derweesh, I. H., Emamekhoo, H., Feldman, D. R., Geynisman, D. M., Hancock, S. L., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0058 · Cited by 450
Colby, S. L., & Ortman, J. M. (2015) · Cited by 437
Steele, C. B., Thomas, C. C., Henley, S. J., Massetti, G. M., Galuska, D. A., Agurs-Collins, T., Puckett, M., & Richardson, L. C. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6639e1 · Cited by 408
Self-citationDavies, L., Morris, L. G. T., Haymart, M., Chen, A. Y., Goldenberg, D., Morris, J., Ogilvie, J. B., Terris, D. J., Netterville, J., Wong, R. J., et al. (2015) · Endocrine Practice · doi:10.4158/ep14466.dscr · Cited by 327
Ward, E. M., Sherman, R. L., Henley, S. J., Jemal, A., Siegel, D. A., Feuer, E. J., Firth, A. U., Kohler, B. A., Scott, S., Ma, J., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz106 · Cited by 323
Self-citationImpact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
The past, present, and future of cancer incidence in the United States: 1975 through 2020
Weir, H. K., Thompson, T. D., Soman, A., Møller, B., & Leadbetter, S. (2015) · Cancer · doi:10.1002/cncr.29258 · Cited by 276
Self-citationCancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001–2009
Siegel, D. A., King, J., Tai, E., Buchanan, N., Ajani, U. A., & Li, J. (2014) · Pediatrics · doi:10.1542/peds.2013-3926 · Cited by 275
Heart Disease and Cancer Deaths — Trends and Projections in the United States, 1969–2020
Weir, H. K., Anderson, R. N., Coleman King, S. M., Soman, A., Thompson, T. D., Hong, Y., Moller, B., & Leadbetter, S. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.160211 · Cited by 270
Self-citationUterine Cancer Incidence and Mortality — United States, 1999–2016
Henley, S. J., Miller, J. W., Dowling, N. F., Benard, V. B., & Richardson, L. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6748a1 · Cited by 246
Self-citationColorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · JAMA · doi:10.1001/jama.2017.7630 · Cited by 242
Self-citationNegoita, S., Feuer, E. J., Mariotto, A., Cronin, K. A., Petkov, V. I., Hussey, S. K., Benard, V., Henley, S. J., Anderson, R. N., Fedewa, S., et al. (2018) · Cancer · doi:10.1002/cncr.31549 · Cited by 239
Self-citationVergamini, L. B., Frazier, A. L., Abrantes, F. L., Ribeiro, K. B., & Rodriguez-Galindo, C. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.059 · Cited by 227
Recent Clinical Advances in Lung Cancer Management
Johnson, D. H., Schiller, J. H., & Bunn, P. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.1228 · Cited by 221
Epidemiologic Signatures in Cancer
Welch, H. G., Kramer, B. S., & Black, W. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1905447 · Cited by 211
Annual financial impact of well‐differentiated thyroid cancer care in the United States
Lubitz, C. C., Kong, C. Y., McMahon, P. M., Daniels, G. H., Chen, Y., Economopoulos, K. P., Gazelle, G. S., & Weinstein, M. C. (2014) · Cancer · doi:10.1002/cncr.28562 · Cited by 188
Thyroid Cancer Following Childhood Low-Dose Radiation Exposure: A Pooled Analysis of Nine Cohorts
Lubin, J. H., Adams, M. J., Shore, R., Holmberg, E., Schneider, A. B., Hawkins, M. M., Robison, L. L., Inskip, P. D., Lundell, M., Johansson, R., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3529 · Cited by 166
de Moor, J. S., Cohen, R. A., Shapiro, J. A., Nadel, M. R., Sabatino, S. A., Yabroff, K. R., Fedewa, S. A., Lee, R., Doria-Rose, V. P., Altice, C., et al. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.05.001 · Cited by 149
Henley, S. J., Thomas, C. C., Lewis, D. R., Ward, E., Islami, F., Wu, M., Weir, H. K., Scott, S., Sherman, R., Ma, J., et al. (2020) · Cancer · doi:10.1002/cncr.32801 · Cited by 141
Self-citationObesity and Risk of Thyroid Cancer: Evidence from a Meta-Analysis of 21 Observational Studies
Wang, H. (2015) · Medical Science Monitor · doi:10.12659/msm.892035 · Cited by 134
The National Vital Statistics System
Rothwell, C. J., Freedman, M. A., & Weed, J. A. (2013) · Health informatics · doi:10.1007/978-1-4471-4237-9_17 · Cited by 128
Henley, S. J., Thomas, C. C., Sharapova, S. R., Momin, B. R., Massetti, G. M., Winn, D. M., Armour, B. S., & Richardson, L. C. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544a3 · Cited by 119
Self-citationGoswami, S., Peipert, B. J., Mongelli, M. N., Kurumety, S. K., Helenowski, I., Yount, S., & Sturgeon, C. (2019) · Surgery · doi:10.1016/j.surg.2019.01.034 · Cited by 101
State Variation in Early-Onset Colorectal Cancer in the United States, 1995–2015
Siegel, R. L., Medhanie, G. A., Fedewa, S. A., & Jemal, A. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz098 · Cited by 88
Self-citationBrown, M. L., Klabunde, C. N., Cronin, K. A., White, M. C., Richardson, L. C., & McNeel, T. S. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.130174 · Cited by 72
Self-citationKehm, R. D., Osypuk, T. L., Poynter, J. N., Vock, D. M., & Spector, L. G. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26888 · Cited by 34
Uprety, D., Bista, A., Chennamadhavuni, A., Niroula, A., Jafri, S. I. M., Smith, A., & Arjyal, L. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000394 · Cited by 27
Puckett, M., Neri, A., Rohan, E. A., Clerkin, C., Underwood, J. M., Ryerson, A. B., & Stewart, S. L. (2016) · Public Health Reports · doi:10.1177/003335491613100119 · Cited by 6
Cited by
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Self-citationGlobal epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
Lu, K. H., & Broaddus, R. R. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1514010 · Cited by 663
Medical Care Costs Associated with Cancer Survivorship in the United States
Mariotto, A. B., Enewold, L., Zhao, J., Zeruto, C. A., & Yabroff, K. R. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1534 · Cited by 634
Metadata
- Authors
- Henley, S. J., Ward, E. M., Scott, S., Ma, J., Anderson, R. N., Firth, A. U., Thomas, C. C., Islami, F., Weir, H. K., Lewis, D. R., Sherman, R. L., Wu, M., Benard, V. B., Richardson, L. C., Jemal, A., Cronin, K., & Kohler, B. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2020-03-12
- Volume
- 126
- Issue
- 10
- Pages
- 2225-2249
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W4251110191
- Cited by
- 853
- References
- 53
- FWCI
- 50.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.